These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16698314)

  • 1. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid.
    Malle E; Marsche G; Arnhold J; Davies MJ
    Biochim Biophys Acta; 2006 Apr; 1761(4):392-415. PubMed ID: 16698314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
    Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
    Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins.
    Hazell LJ; Davies MJ; Stocker R
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine.
    Heinecke JW
    Biofactors; 1997; 6(2):145-55. PubMed ID: 9259996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human low density lipoprotein as a target of hypochlorite generated by myeloperoxidase.
    Jerlich A; Fabjan JS; Tschabuschnig S; Smirnova AV; Horakova L; Hayn M; Auer H; Guttenberger H; Leis HJ; Tatzber F; Waeg G; Schaur RJ
    Free Radic Biol Med; 1998 May; 24(7-8):1139-48. PubMed ID: 9626568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro.
    Yang CY; Gu ZW; Yang M; Lin SN; Garcia-Prats AJ; Rogers LK; Welty SE; Smith CV
    J Lipid Res; 1999 Apr; 40(4):686-98. PubMed ID: 10191293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
    Hazen SL; Heinecke JW
    J Clin Invest; 1997 May; 99(9):2075-81. PubMed ID: 9151778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
    Van Antwerpen P; Legssyer I; Zouaoui Boudjeltia K; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
    Eur J Pharmacol; 2006 May; 537(1-3):31-6. PubMed ID: 16631159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloperoxidase-generated oxidants and atherosclerosis.
    Podrez EA; Abu-Soud HM; Hazen SL
    Free Radic Biol Med; 2000 Jun; 28(12):1717-25. PubMed ID: 10946213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis.
    Hazell LJ; Baernthaler G; Stocker R
    Free Radic Biol Med; 2001 Nov; 31(10):1254-62. PubMed ID: 11705704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Myeloperoxidase Oxidants in the Modulation of Cellular Lysosomal Enzyme Function: A Contributing Factor to Macrophage Dysfunction in Atherosclerosis?
    Ismael FO; Barrett TJ; Sheipouri D; Brown BE; Davies MJ; Hawkins CL
    PLoS One; 2016; 11(12):e0168844. PubMed ID: 27997605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
    Malle E; Marsche G; Panzenboeck U; Sattler W
    Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
    Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
    Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction.
    Abdo AI; Rayner BS; van Reyk DM; Hawkins CL
    Redox Biol; 2017 Oct; 13():623-632. PubMed ID: 28818791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of low-density lipoprotein modification by myeloperoxidase with hypochlorous acid formation.
    Jerlich A; Horakova L; Fabjan JS; Giessauf A; Jürgens G; Schaur RJ
    Int J Clin Lab Res; 1999; 29(4):155-61. PubMed ID: 10784377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation.
    Miller YI; Felikman Y; Shaklai N
    Arch Biochem Biophys; 1996 Feb; 326(2):252-60. PubMed ID: 8611031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oxidation on the structure and stability of human low-density lipoprotein.
    Jayaraman S; Gantz DL; Gursky O
    Biochemistry; 2007 May; 46(19):5790-7. PubMed ID: 17444660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo.
    Hazen SL; Zhang R; Shen Z; Wu W; Podrez EA; MacPherson JC; Schmitt D; Mitra SN; Mukhopadhyay C; Chen Y; Cohen PA; Hoff HF; Abu-Soud HM
    Circ Res; 1999 Nov; 85(10):950-8. PubMed ID: 10559142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorination and oxidation of the extracellular matrix protein laminin and basement membrane extracts by hypochlorous acid and myeloperoxidase.
    Nybo T; Dieterich S; Gamon LF; Chuang CY; Hammer A; Hoefler G; Malle E; Rogowska-Wrzesinska A; Davies MJ
    Redox Biol; 2019 Jan; 20():496-513. PubMed ID: 30476874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways of phospholipid oxidation by HOCl in human LDL detected by LC-MS.
    Jerlich A; Pitt AR; Schaur RJ; Spickett CM
    Free Radic Biol Med; 2000 Mar; 28(5):673-82. PubMed ID: 10754262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.